Dr. Dinesh Singh – Director, Radiation Oncology

  • Current Position:
    Director, Radiation Oncology at Action Cancer Hospital, Paschim Vihar, Delhi
  • Educational Background:
    • MBBS from University College of Medical Sciences (UCMS), Delhi University
    • MD in Radiotherapy from Maulana Azad Medical College (MAMC), Delhi University
  • Professional Experience:
    • Over 35 years in the field of Radiation Oncology
    • Former positions at:
      • LNJPN Hospital & Maulana Azad Medical College, Delhi
      • Tata Memorial Hospital, Mumbai
      • Dharamshila Cancer Hospital and Research Centre, Delhi
      • Galaxy Cancer Institute, Pushpanjali Crosslay Hospital, Vaishali, Ghaziabad
      • Max Super Speciality Hospital, Vaishali and Pitampura, Delhi
      • Valentis Cyberknife Cancer Hospital, Meerut
    • International experience at:
      • Stadt Kliniken, Frankfurt University, Offenbach, Germany
      • University of Texas Medical Branch, Galveston, Texas, USA
      • Long Beach Memorial Medical Centre, California, USA
      • Ohio State University, Columbus, Ohio, USA
      • Memorial Sloan Kettering Cancer Centre, New York, USA
      • Roswell Park Cancer Institute, Buffalo, New York, USA
      • Orange County Cyberknife Centre, California, USA
  • Clinical Expertise:
    • Specializes in advanced radiation therapy techniques including:
      • Image-Guided Radiotherapy (IGRT)
      • Intensity-Modulated Radiotherapy (IMRT)
      • Stereotactic Body Radiotherapy (SBRT)
      • Conformal Radiotherapy
      • Brachytherapy
    • Expertise in treating various cancers such as:
      • Head and Neck Cancers
      • Brain Tumors
      • Breast Cancer
      • Thoracic Cancers
      • Gastrointestinal Cancers
      • Urological Cancers
  • Research & Publications:
    • Presented research at international forums:
      • “Concomitant Chemoradiotherapy in the Management of Advanced Cancers of Hypopharynx and Larynx” at the INCTR Annual Meeting in Brussels, Belgium (2003)
      • “Interstitial Brachytherapy in Recurrent Malignant Gliomas” at the Asia Pacific Cancer Congress in Chennai, India (2000)
      • “2-Deoxyglucose as an Adjuvant in Improving Radiotherapy of Malignant Gliomas” at the 12th International Congress on Radiation Research in Brisbane, Australia (2003)
      • “Concurrent Chemoradiotherapy in Cancer Cervix” at the INCTR Annual Meeting in Cairo, Egypt (2004)
  • Professional Memberships:
    • Member of the Association of Radiation Oncologists of India (AROI)
    • Member of the Indian Society of Oncology (ISO)
    • Member of the Indian Medical Association (IMA)
  • Languages Spoken:
    • English
    • Hindi
Scroll to Top